Costs, evidence, and value in the Medicare program: the challenges of technology innovation in breast cancer prevention and control
JAMA Intern Med
.
2013 Feb 11;173(3):227-8.
doi: 10.1001/jamainternmed.2013.2127.
Authors
Jeanne S Mandelblatt
1
,
Anna N A Tosteson
,
Nicolien T van Ravesteyn
Affiliation
1
Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, USA.
[email protected]
PMID:
23303388
PMCID:
PMC4071606
DOI:
10.1001/jamainternmed.2013.2127
No abstract available
Publication types
Research Support, N.I.H., Extramural
Comment
MeSH terms
Breast Neoplasms / diagnosis*
Female
Humans
Mass Screening / economics*
Medicare / economics*
Grants and funding
U01 CA152958/CA/NCI NIH HHS/United States
U54CA163307/CA/NCI NIH HHS/United States
RC2CA148577/CA/NCI NIH HHS/United States
U01CA088283/CA/NCI NIH HHS/United States
U54 CA163307/CA/NCI NIH HHS/United States
P01 CA154292/CA/NCI NIH HHS/United States
K05 CA096940/CA/NCI NIH HHS/United States
U01CA152958/CA/NCI NIH HHS/United States
K05CA96940/CA/NCI NIH HHS/United States
U01 CA088283/CA/NCI NIH HHS/United States
P01CA154292/CA/NCI NIH HHS/United States
RC2 CA148577/CA/NCI NIH HHS/United States